Medidata Remote Source Review Software-as-a-Service for Electronic Monitoring of Clinical Studies Presolicitation
Overview
Fit Score
Settle Intelligence
Settle helps teams find, evaluate, and respond to public RFPs. We continuously surface new opportunities, score them against your company strengths, and draft proposal responses so you can focus on the work that wins business.
SUMMARY
DESCRIPTION
The National Institute of Allergy and Infectious Diseases (NIAID) is planning to renew its licenses for the Medidata Remote Source Review Software-as-a-Service module, used for electronic monitoring of clinical studies. This technology supports the Division of AIDS in managing clinical site monitoring within a validated environment, ensuring adherence to federal and international regulations.
The planned contract will cover a six-month period from January 1, 2026, to June 30, 2026. This renewal is intended to maintain continuous Remote Source Review capabilities that are critical to the agency's clinical research oversight. The Medidata software is considered essential to meet NIAID’s operational requirements for secure, compliant clinical site management.
Source attribution
This Settle analysis is based on the issuing organization’s public RFP listing.